文献速递乳腺癌放疗放疗物理与技术

基于丹麦乳腺癌协作组RT Nation研究的6925例高危乳腺癌患者心脏放疗剂量人群审计

Population based audit of heart radiation doses in 6925 high-risk breast cancer patients from the Danish breast cancer group RT Nation study.
PubMed 文献 · Radiother Oncol · 2024-11-16

该研究对2008—2016年丹麦七家放疗中心收治的6925例接受辅助放疗的高危乳腺癌患者进行回顾性人群审计,使用自动勾画工具建立同质化队列评估心脏剂量。同质化队列中位平均心脏剂量为1.58 Gy,左侧患者为2.14 Gy、右侧为1.08 Gy,临床勾画心脏体积中位数从2008年531.9 ml增至2016年638.5 ml。

要点

  • 同质化队列中位平均心脏剂量为1.58 Gy,左侧患者2.14 Gy,右侧患者1.08 Gy。
  • 临床勾画心脏体积中位数从2008年531.9 ml增至2016年638.5 ml(P<0.01)。
  • 6925例中5589例(81%)有临床心脏勾画,临床勾画心脏中位平均心脏剂量比同质化队列计划值低0.01 Gy。

核心结论

  • 2008—2016年间该人群的计划心脏剂量整体较低,同质化队列中位平均心脏剂量为1.58 Gy。
  • 临床勾画心脏体积随时间增加,但同质化队列中位平均心脏剂量仍低。
  • 研究展示了使用自动分割工具开展全人群、一致性剂量审计的可能性。

研究设计与样本

  • 研究为基于人群的回顾性审计,纳入2008—2016年丹麦全部七家放疗中心接受辅助放疗的高危乳腺癌患者。
  • 使用内部开发的自动分割工具建立同质化队列,评估同质化队列体积及计划剂量(平均心脏剂量、V20Gy和V40Gy)。
  • 比较临床勾画心脏与同质化心脏的体积和剂量指标。

主要发现

  • 共纳入6925例患者,其中5589例(81%)有临床心脏勾画。
  • 临床勾画心脏体积中位数从2008年531.9 ml增至2016年638.5 ml(P<0.01)。
  • 同质化队列2008—2016年中位平均心脏剂量为1.58 Gy,整体呈下降趋势;左侧患者为2.14 Gy,右侧患者为1.08 Gy。
  • 临床勾画心脏的中位平均心脏剂量比同质化队列计划中位平均心脏剂量低0.01 Gy。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: In this study, we conducted a population-based retrospective audit of heart doses for high-risk breast cancer (BC) over a nine-year period in patients treated with adjuvant CT-based radiotherapy in a comprehensive and homogenized national BC cohort. Additionally, this serves as a demonstration of performing large scale audits with consistent delineations created by an auto-segmentation tool. MATERIALS AND METHODS: High-risk BC patients treated with adjuvant radiotherapy in the period 2008-2016 from all seven radiotherapy centres in Denmark were included. A homogenized cohort was created using an inhouse developed auto-segmentation tool. The homogenized cohort volume and planned doses (mean heart dose (MHD), V20Gy and V40Gy) were evaluated. Volumes and dose metrics were compared for clinical and homogenized heart volumes. RESULTS: Among 6925 patients, 5589(81 %) had a clinical heart delineation. The median delineated heart volume increased from 531.9 ml (2008) to 638.5 ml (2016) (p < 0.01). The median MHD for the homogenized cohort was 1.58 Gy (2008-2016) with an overall decreasing trend, 2.14 Gy in left- and 1.08 Gy in right-sided patients. The median MHD in the clinically delineated hearts was 0.01 Gy lower than the planned median MHD in the homogenized cohort. CONCLUSION: During 2008-2016 the planned heart dose has been low across the population. A volume increase was observed in the clinically delineated hearts, however the median MHD in the homogenized cohort was low, with 1.58 Gy. The study demonstrated the possibilities for full population-based and consistent dose audit by using auto-segmentation tools.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Buhl ES, Refsgaard LH, Al-Rawi SA, et al. Population based audit of heart radiation doses in 6925 high-risk breast cancer patients from the Danish breast cancer group RT Nation study. Radiother Oncol. 2024. PMID: 39557125. doi:10.1016/j.radonc.2024.110643

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。